The role of intravitreal anti-vascular endothelial growth factor injection in peripheral exudative hemorrhagic chorioretinopathy: A systematic review

Anti-vascular endothelial growth factor (anti-VEGF) injections have revolutionised the field of ophthalmology, and their use in a variety of retinal diseases is growing. One target disease is peripheral exudative haemorrhagic chorioretinopathy (PEHCR), a disease that is uncommon and poorly understood. Despite this, there are numerous studies and case reports outlining the potential role of intravitreal injection of anti-VEGF medicines to treat it. As such, an evidence-based understanding of its risk-benefit profile is vital.
Source: Survey of Ophthalmology - Category: Opthalmology Authors: Source Type: research